Moreover, the data seem to point towards a priority role for IL-23, which would also be responsible for the consequent secretion of IL-17 and the acute exacerbation of pulmonary fibrosis; in fact, by blocking the secretion of IL-23, the release of IL-17 is also decreased [50]. The gene discussed is IL23A; the disease is pulmonary fibrosis.